THC Therapeutics, Inc.
THCT
$0.0001
-$0.0002-66.67%
OTC PK
| 04/30/2024 | 01/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 345.66% | 54.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 345.66% | 54.35% | |||
| Operating Income | -345.66% | -54.35% | |||
| Income Before Tax | 118.29% | -815.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 118.29% | -815.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 118.29% | -815.20% | |||
| EBIT | -345.66% | -54.35% | |||
| EBITDA | -347.41% | -54.46% | |||
| EPS Basic | 115.52% | -815.79% | |||
| Normalized Basic EPS | 115.60% | -808.33% | |||
| EPS Diluted | 115.52% | -815.79% | |||
| Normalized Diluted EPS | 115.60% | -808.33% | |||
| Average Basic Shares Outstanding | 16.64% | 0.37% | |||
| Average Diluted Shares Outstanding | 16.64% | 0.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||